COVID-19 and Its Potential Effect on Patients With Rheumatic Diseases in Latin America.

Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
Claudia Elera-FitzcarraldGraciela S Alarcón

Abstract

The COVID-19 (coronavirus disease 2019) pandemic has dramatically affected the entire world. Because of significant disparity levels in Latin American countries with deficient health care access and significant poverty, their population may end up among the most severely impacted. Patients with chronic conditions such as rheumatic diseases are quite vulnerable because of their high flaring risks and subsequent poor outcomes. Additionally, an overuse of antimalarials for the treatment of COVID-19 could lead to shortages in our region. Telemedicine, personal protective equipment use by patients and providers, web conferences, and comprehensive care are tools that will contribute to reduce the risk of infections and other complications in rheumatic disease patients, as well as to improve the knowledge and experience of rheumatologists at a global level.

References

Jan 5, 2002·Arthritis and Rheumatism·G S AlarcónUNKNOWN LUMINA Study Group. Lupus in Minority Populations, Nature versus Nurture
Jul 27, 2012·Arthritis Care & Research·Jessica WiddifieldClaire Bombardier
Aug 31, 2012·Arthritis and Rheumatism·Michelle PetriLaurence S Magder
Jul 21, 2015·Clinical Rheumatology·Manuel F Ugarte-GilBernardo A Pons-Estel
Mar 10, 2016·Current Rheumatology Reports·Sarah DoatyDaniel E Furst
May 4, 2017·Seminars in Immunopathology·Rudragouda Channappanavar, Stanley Perlman
Feb 23, 2020·The Lancet. Respiratory Medicine·Zhe XuFu-Sheng Wang
Mar 11, 2020·Lancet·Helena Legido-QuigleyDavid Heymann
Mar 21, 2020·Lancet·Juliet BedfordUNKNOWN WHO Strategic and Technical Advisory Group for Infectious Hazards
Mar 25, 2020·Autoimmunity Reviews·Ennio Giulio FavalliRoberto Caporali
Apr 3, 2020·Frontiers of Medicine·Min ZhouJieming Qu
Apr 10, 2020·The Journal of Rheumatology·Michael S Putman, Eric M Ruderman
Apr 21, 2020·The Lancet Rheumatology·Milena A GianfrancescoUNKNOWN COVID-19 Global Rheumatology Alliance Steering Committee
Apr 24, 2020·Pediatric Rheumatology Online Journal·Francesco LicciardiRolando Cimaz
Apr 30, 2020·The New England Journal of Medicine·Rebecca HabermanJose U Scher

❮ Previous
Next ❯

Citations

Sep 26, 2020·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Abdulsamet SandalMetin Akgün
Jul 10, 2021·Multiple Sclerosis and Related Disorders·Anibal ChertcoffRicardo Alonso
Dec 11, 2020·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Ennio LubranoLuca Brunese

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.